價格 | ¥1138 | ¥1880 |
包裝 | 50ul | 100ul |
最小起訂量 | 50ul |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-27 |
中文名稱:Anti-IKB alpha antibody-核因子κB抑制蛋白α單克隆抗體 | 英文名稱:IKB alpha |
品牌: 滬震生物 | 產(chǎn)地: 中國/上海 |
保存條件: -20°C | 純度規(guī)格: > 99% |
產(chǎn)品類別: 抗體 一抗 | |
抗體名: NFKBIA; Inhibitor of KB alpha; I kappa B alpha; I(Kappa)B(alpha); IkappaBalpha; IKBA; IKBalpha; MAD 3; MAD3; Major histocompatibility complex enhancer binding protein MAD3; NF kappa B inhibitor alpha; NFKBI; NFKBIA; Nuclear factor of kappa light chain gene enhancer in B cells; Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor alpha; IKBA_HUMAN. | 靶點: 詳見說明書 |
宿主: Mouse | 適應物種: 詳見說明書 |
克隆性: 詳見說明書 | 濃度: 1mg/ml |
應用范圍: WB=1:500-2000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復) not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. | 標識物: 詳見說明書 |
形態(tài): 液體 | 亞型: IgG1 |
免疫原: 詳見說明書 | 貨號: Hz-M33441 |
用途范圍: 科研使用 | 規(guī)格: 50ul/100ul |
是否進口: 否 | 是否單克隆: 詳見說明書 |
保質期: 12個月 | 抗原來源: 詳見說明書 |
標記物: 詳見說明書 | 產(chǎn)品用途: WB=1:500-2000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復) not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
Mouse Anti-IKB alpha Monoclonal Antibody
DATASHEET
Host:Mouse
Target Protein:IKB alpha
IR:Immunogen Range:1-77/314
Clonality:Monoclonal
Isotype:IgG1
Entrez Gene:4792
Swiss Prot:P25963
Source:Recombinant human IKB alpha Protein:1-77/314
Purification:affinity purified by Protein A
Storage:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
Background:Three major forms of IKB like molecules have been identified and each is characterised by multiple copies of ankyrin repeats. IKB alpha and IKB beta appear to be the major regulatory forms of IKB in most cells. These proteins interact with p65 or cRel containing forms of NFkB and block nuclear import by masking the nuclear localisation sequences of NFkB. The activation of NFkB involves the inducible phosphorylation and subsequent degradation of IKB. Immunoblotting easily detects the hyperphosphorylated forms of IKB alpha, but not phosphorylated IKB beta. Interestingly, IKB alpha and IKB beta mediate different NFkB responses. IkB alpha appears to control more transient activation of NFkB in response to an inducer, while IKB beta controls a persistent response. Bcl3 interacts with p50 and p52 containing forms of NFkB, but rather than being an inhibitor it appears to function to stimulate transcription. The degradation of IKB is confirmed by immunoblotting.
Size:50ul
Concentration:1mg/ml
Applications:WB(1:500-2000)
IHC-P(1:100-500)
IHC-F(1:100-500)
ICC(1:100-500)
IF(1:100-500)
Cross Reactive Species:Human
Mouse
Rat
僅供科研使用。不能用于人和動物治療等其它臨床診斷用!
成立日期 | 2014-05-08 (11年) | 注冊資本 | 100萬元整 |
員工人數(shù) | 10-50人 | 年營業(yè)額 | ¥ 100萬以內(nèi) |
主營行業(yè) | 生化試劑,細胞培養(yǎng),蛋白組學,分子生物學,細胞生物學 | 經(jīng)營模式 | 工廠,試劑,定制,服務 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥1200 |
VIP3年
|
上海雅吉生物科技有限公司
|
2024-12-27 | |
¥2780 |
VIP4年
|
上海博爾森生物科技有限公司
|
2024-12-27 | |
詢價 |
上海將來實業(yè)股份有限公司
|
2024-12-25 |